Ryan & Maniskas, LLP Announces Investigation of Blyth, Inc.
WAYNE, Pa., Nov. 1, 2013 /PRNewswire/ -- Ryan & Maniskas, LLP is investigating potential claims against the board of directors of Blyth, Inc. ("Blyth" or the "Company") (NYSE: BTH) for potential breaches of fiduciary duties in connection with their conduct related to the proposed sale of the Company to CVSL Inc. in a cash deal valued at approximately $269 million.
If you own shares of Blyth and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or to sign up online, visit: www.rmclasslaw.com/cases/bth. You may also email Mr. Maniskas at firstname.lastname@example.org.
Under the terms of the proposed transaction, Blyth's stockholders will receive $16.75 for each share of Blyth common stock they own.
The investigation concerns the Company's board of directors' process for consideration of the proposed transaction, whether it is acting in its shareholders' best interests and whether the proposed consideration to be paid to Blyth's shareholders would be fair and adequate.
Ryan & Maniskas, LLP is a national shareholder litigation firm. Ryan & Maniskas, LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide. For more information about class action cases in general, please visit our website: www.rmclasslaw.com.
SOURCE Ryan & Maniskas, LLP
More by this Source
Ryan & Maniskas, LLP Announces Investigation of Target Corp.
Mar 07, 2014, 19:00 ET
Ryan & Maniskas, LLP Announces Investigation of Safeway Inc.
Mar 07, 2014, 10:49 ET
Ryan & Maniskas, LLP Announces Class Action Lawsuit Against LifeLock, Inc.
Mar 05, 2014, 18:15 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.